What is the Soleno Therapeutics Inc (SLNO) price today?

The price of Soleno Therapeutics Inc (SLNO) today is $52.78. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/SLNO

Buy & Sell Soleno Therapeutics Inc (SLNO) – Soleno Therapeutics Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Soleno Therapeutics (SLNO) trades at $52.78, up 0.4% on the day, with a strong analyst consensus of Buy (61.5% of 13 analysts) and a $58.40 price target. The stock shows elevated valuation multiples (P/E 135.31, P/S 14.52) but has delivered three consecutive quarterly earnings beats, with Q4 2025 EPS of $0.80 beating expectations by 25%. Recent news is dominated by multiple law firms announcing a securities class action lawsuit related to the period between March 26, 2025 and November 4, 2025.

The outlook balances strong earnings momentum and analyst optimism against significant legal overhang and premium valuations. Investment opportunity centers on continued execution and potential resolution of legal matters, while primary risks include the pending class action outcome, high valuation sensitivity to growth expectations, and the company's negative net cash flow position of -$18M in 2025.

Read full analysis

Key Stats

Market Cap
$2.73B
Sector
Health
3M Drawdown
-31.67%
Enterprise Value
$2.48B
Dividend Yield
-

$52.78

52W Low: $30.05

27 Mar 2026

52W High: $88.49

09 Jul 2025

Soleno Therapeutics Inc (SLNO) is currently valued at a market capitalization of $2.73B, with an enterprise value of $2.48B. Over the past 52 weeks, Soleno Therapeutics Inc has traded between a low of $30.05 and a high of $88.49, highlighting its annual price range. Over the past three months, Soleno Therapeutics Inc has recorded a drawdown of -31.67%, reflecting recent price volatility.

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases. The company's lead product candidate, DCCR (Diazoxide Choline Extended-Release), is currently in late-stage clinical trials for the treatment of Prader-Willi Syndrome (PWS), a complex genetic disorder that causes a constant feeling of hunger (hyperphagia). Soleno is committed to addressing the significant unmet medical need in the PWS community.

Technical Indicators

Overall Summary

Bearish (5)Neutral (4)Bullish (14)

News

Globe Newswire4 day ago

Halper Sadeh LLC is Investigating Whether AVNS, LEG, SLNO, FORA are Obtaining Fair Deals for their Shareholders

Globe Newswire6 day ago

Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors

Globe Newswire10 day ago

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SMCI

Globe Newswire10 day ago

ROSEN, A LEADING LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EOSE

Globe Newswire10 day ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$2.73B
Sector
Health
3M Drawdown
-31.67%
Enterprise Value
$2.48B
Dividend Yield
-

$52.78

52W Low: $30.05

27 Mar 2026

52W High: $88.49

09 Jul 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Soleno Therapeutics Inc (SLNO) – Soleno Therapeutics Inc Price Today

Aura AI Summary

Key Stats

About Soleno Therapeutics Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store